cjc-1295 ipamorelin igf-1 increase levels IPA/CJC/IGF BLEND CJC-1295 / Ipamorelin – My
Description
2014 Feb;31(2):229-39

Twenty-five healthy rats (weighing 200220 g) were divided into a negative control group (0), a placebo group (0.9% saline), and three treatment groups (15, 30, and 45 mg per kg of body weight)

Results indicated that 300 mg/kg of this extract significantly reduced hypertension, improved vasorelaxation, and mitigated left ventricular hypertrophy

PerellMCornejoMPDe FrancescoPNFernandezGGautronLValdiviaLS